Companies /Basic Materials

Eastman Chemical Company

NYSE: EMN Specialty Chemicals
$68.34
▼ $2.05 (−2.91%) today
Markets closed · 7:15pm ET

Q4 2025 Earnings

Reported Jan 29, 2026, 4:16pm ET · SEC source
$0.75
Beat +4.15%
EPS · est. $0.72
$2.0B
Miss −2.09%
Revenue · est. $2.0B
+7.0%
Beating market
EMN vs S&P since report
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0+3%Jan 29Jan 30report 4:16pm ETearnings−0.3%+0.5%
−3%0+3%Jan 29Jan 30earnings−0.3%+0.5%
EMN +0.5%S&P 500 −0.3%
−3%0+3%Jan 29Jan 30report 4:16pm ETearnings−1.3%+0.5%
−3%0+3%Jan 29Jan 30earnings−1.3%+0.5%
EMN +0.5%NASDAQ −1.3%
0+7%+14%+21%Jan 28Feb 6report 4:16pm ETearnings−0.5%+17.3%
0+7%+14%+21%Jan 28Feb 6earnings−0.5%+17.3%
EMN +17.3%S&P 500 −0.5%
0+8%+16%Jan 28Feb 6report 4:16pm ETearnings−3.2%+17.3%
0+8%+16%Jan 28Feb 6earnings−3.2%+17.3%
EMN +17.3%NASDAQ −3.2%
+0.48%
Day of report
+3.12%
Next session
+11.70%
One week
+5.96%
30 days

S&P 500 over the same 30 days: −0.99%.

Did EMN Beat Earnings? Q4 2025 Results

Eastman Chemical delivered a mixed fourth quarter for fiscal 2025, squeezing out a narrow earnings beat against a backdrop of sharply declining sales. The specialty materials company posted adjusted EPS of $0.75, edging past the $0.72 consensus estimate by 4.17%, but revenue slid 12.1% year-over-year to $1.97 billion, falling short of the $2.01 billion analysts had expected. The primary culprit was a brutal combination of acetate tow destocking in the Fibers segment, which plunged 27%, and broad volume weakness across consumer discretionary end markets, with lower capacity utilization and pricing pressure from Asian competition compounding the damage in Chemical Intermediates. Full-year 2025 revenue declined 7% to $8.75 billion, prompting questions about the durability of Eastman's efficiency and sustainability strategy under persistent market headwinds. Management declined to issue a full-year 2026 EPS target citing macroeconomic uncertainty, but guided Q1 2026 adjusted EPS to $1.00 to $1.20, pointing to $125 million to $150 million in structural cost reductions and continued methanolysis growth as the primary engines of recovery.

Key Takeaways
  • Commercial excellence in defending product value amid weak economic environment
  • Cost reduction initiatives exceeded $100 million target versus goal of greater than $75 million
  • Lower sales volume/mix driven by customer inventory destocking in acetate tow and consumer discretionary weakness
  • Unfavorable price-cost dynamics partially offset by lower variable compensation expense
  • Increased competitive pressure from Asia impacting Chemical Intermediates pricing
  • Higher-than-usual seasonal demand declines as customers leveraged prepositioned inventory to mitigate tariff impacts

“Despite a challenging operating environment for the chemical industry and continued weakness in consumer discretionary end markets, our team delivered a year that demonstrates the strength of our portfolio's ability to generate cash. In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management. Our commercial teams showed excellence in defending the value of our products, and we accelerated our structural cost reductions throughout the year to protect margins and preserve competitiveness.”

Eastman Chemical CEO, on the earnings call

Forward Guidance & Outlook

For 2026, Eastman expects meaningful earnings improvement versus 2025 driven by: (1) increased cost structure reduction actions of $125-$150 million; (2) continued innovation-driven growth led by the methanolysis facility; (3) improved manufacturing utilization with fewer shutdowns; and (4) favorable foreign currency exchange rates. These are expected to be partially offset by variable compensation expense resetting, lower spreads in Chemical Intermediates, modest Fibers price declines, and higher energy costs. Operating cash flow is expected to be similar to 2025. The company is not providing a full-year adjusted EPS range due to significant macroeconomic uncertainty. For Q1 2026, adjusted EPS is expected to be between $1.00 and $1.20, reflecting solid seasonal volume growth, reduced customer caution, lower shutdown costs, and continuing cost reduction actions, partially offset by lower prices in Fibers and Chemical Intermediates and higher energy costs.

EMN YoY Financials

Q4 2025 vs Q4 2024 · SEC filings Q4 2024 Q4 2025
$0$700.0M$1.4B$2.1B$2.2B$2.0BRevenue$554.0M$338.0MGross Profit$378.0M$64.0MOperating Income$330.0M$105.0MNet Income
$0$700.0M$1.4B$2.1BRevenueGross ProfitOperating IncomeNet Income

EMN Revenue by Segment

Advanced Materials$656.0M−9.0%
Additives & Functional Products$662.0M−5.0%
Chemical Intermediates$418.0M−17.0%
Fibers$234.0M−27.0%

EMN Revenue by Geography

North America$863.0M
EMEA$521.0M
Asia Pacific$481.0M
Latin America$108.0M

Figures from SEC filings and company reports. Not investment advice.